Atara Biotherapeutics, Inc.

Atara Biotherapeutics provides a regulatory update on Tabelecleucel after a meeting with the FDA. The FDA agreed a single arm study could be sufficient for resubmission. PFP plans to submit an updated dataset with more patients.

Atara Biotherapeutics, Inc. ATRA is headquartered in Thousand Oaks, CA.

Source